心房顫動偵測專利技術(shù)
邁克大夫的 AFIB 心房顫動偵測專利技術(shù)可以在血壓測量過程中偵測心房顫動，當(dāng)屏幕顯示心房顫動圖標(biāo)，提醒您盡早尋求專業(yè)意見。
心房顫動(AFIB)是什么？心房顫動是最致命的一種心律不齊，中風(fēng)風(fēng)險高出五倍邁克大夫的 AFIB 心房顫動偵測專利技術(shù)能有效篩檢出最危 險致命的心律不整 - 心房顫動，排除其他因生理與人為因素 造成的心律不整。經(jīng)由邁克大夫的專利技術(shù)可以在血壓測量 過程中自動偵測心房顫動，使用者在 MAM 三次平均模式下 進(jìn)行測量，如發(fā)現(xiàn)心房顫動，屏幕會顯示圖標(biāo)提醒您盡早尋 求專業(yè)意見，幫助您了解自身健康狀況。 |
.png) |
準(zhǔn)確專注篩檢心房顫動
專業(yè)證實(shí)邁克大夫的心房顫動偵測具有高度敏感性(98%)與高度特異性(92%)
學(xué)術(shù)研究累計(jì)超過 10000 名樣本，
并發(fā)表于國際知名期刊。
經(jīng)專業(yè)研究實(shí)證，在居家量測血壓時，
能同時偵測心房顫動，可作為 AF 初篩的可靠工具。
獲英國國家健康與照顧卓越研究院 NICE 官方正式推薦 :
- 專業(yè)人士推薦 ：No.1 的心房顫動偵測技術(shù)！
- Microlife 邁克大夫的心房顫動偵測技術(shù)，已通過專業(yè)實(shí)驗(yàn)證明了準(zhǔn)確度，有助于篩檢出新的 AFIB 個案。
- 建議使用于可能罹患高血壓的高危險群＆高血壓族群的血壓管理。
國際專業(yè)實(shí)證列表
| Patients (n) | Setting | Average age (y) |
AF n (%) |
Non-AF n (%) |
Sinus (n) | Sensitivity (%) |
Specificity (%) |
|
|---|---|---|---|---|---|---|---|---|
| Wiesel 2004 | 450 | Hospital | 69 | 53(12) | 1 | 396 | 100 | 92 |
| Stergiou 2009 | 73 | Hospital | 71 | 27(37) | 23 | 23 | 100 | 89 |
| Wiesel 2004 | 405 | Hospital | 73 | 93(23) | 64 | 248 | 97 | 89 |
| Wiesel 2004 | 405 | Hospital | 73 | 93(23) | 64 | 248 | 97 | 89 |
| Wiesel 2004 | 405 | Hospital | 73 | 93(23) | 64 | 248 | 97 | 89 |
| Wiesel 2004 | 405 | Hospital | 73 | 93(23) | 64 | 248 | 97 | 89 |
| Wiesel 2004 | 405 | Hospital | 73 | 93(23) | 64 | 248 | 97 | 89 |
2013 Oxford Trail 牛津?qū)I(yè)試驗(yàn)
著名的英國牛津大學(xué)在2013年，針對1,000名家醫(yī)科患者進(jìn)行了一項(xiàng)隨機(jī)專業(yè)試驗(yàn) ，研究結(jié)果表明:
Microlife 邁克大夫的 AFIB 對于心房顫動的初步篩檢來說是最好的選擇，量血壓同時量測，操作簡單不需專業(yè)解釋，準(zhǔn)確度可媲美診間使用的單導(dǎo) ECG，所以在基礎(chǔ)健康管理與居家使用上，Microlife 邁克大夫AFIB 比 ECG 更適合做為房顫的篩檢工具。
這些資料建議使用心房顫動技術(shù)進(jìn)行居家血壓量測，有優(yōu)異的量測準(zhǔn)確度，因此于初期量測時可用來作為可靠的篩檢試驗(yàn)。
– Dr. George S. Stergiou
國際專業(yè)實(shí)證列表
Nichols M TN, Luengo-Fernandez R, Leal J, Gray A, Scarborough P, Rayner M European Cardiovascular Disease Statistics 2012. European Heart Network, Brussels, European Society of Cardiology, Sophia Antipolis 2012.
Boriani G, Laroche C, Diemberger I, Fantecchi E, Popescu MI, Rasmussen LH et al.: Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. Am J Med 2015; 128:509-518 e502.
Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S: Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol 2014; 6:213-220.
Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA et al.: Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014; 370:2478-2486.
Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J et al.: Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med 2014; 370:2467-2477.
Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al.: 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. Europace 2012; 14:1385-1413.
Hart RG, Benavente O, McBride R, Pearce LA: Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999; 131:492-501.
Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD et al.: Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 2014; 383:955-962.
Verberk WJ, Omboni S, Kollias A, Stergiou GS: Screening for atrial fibrillation with automated blood pressure measurement: Research evidence and practice recommendations. Int J Cardiol 2016; 203:465-473.
Wiesel J, Fitzig L, Herschman Y, Messineo FC: Detection of atrial fibrillation using a modified microlife blood pressure monitor. Am J Hypertens 2009; 22:848-852.
Stergiou GS, Karpettas N, Protogerou A, Nasothimiou EG, Kyriakidis M: Diagnostic accuracy of a home blood pressure monitor to detect atrial fibrillation. J Hum Hypertens 2009; 23:654-658.
Wiesel J, Fitzig L, Herschman Y, Messineo FC: Detection of atrial fibrillation using a modified microlife blood pressure monitor. Am J Hypertens 2009; 22:848-852.
Wiesel J, Abraham S, Messineo FC: Screening for asymptomatic atrial fibrillation while monitoring the blood pressure at home: trial of regular versus irregular pulse for prevention of stroke (TRIPPS 2.0). Am J Cardiol 2013; 111:1598-1601.
Kearley K, Selwood M, Van den Bruel A, Thompson M, Mant D, Hobbs FR et al.: Triage tests for identifying atrial fibrillation in primary care: a diagnostic accuracy study comparing single-lead ECG and modified BP monitors. BMJ Open 2014; 4:e004565.
Wiesel J, Arbesfeld B, Schechter D: Comparison of the Microlife blood pressure monitor with the Omron blood pressure monitor for detecting atrial fibrillation. Am J Cardiol 2014; 114:1046-1048.
Gandolfo C, Balestrino M, Bruno C, Finocchi C, Reale N: Validation of a simple method for atrial fibrillation screening in patients with stroke. Neurol Sci 2015; 36:1675-1678.
Chan PH, Wong CK, Pun L, Wong YF, Wong MM, Chu DW et al.: Head-to-Head Comparison of the AliveCor Heart Monitor and Microlife WatchBP Office AFIB for Atrial Fibrillation Screening in a Primary Care Setting. Circulation 2017; 135:110-112.
Chan PH, Wong CK, Pun L, Wong YF, Wong MM, Chu DW et al.: Diagnostic performance of an automatic blood pressure measurement device, Microlife WatchBP Home A, for atrial fibrillation screening in a real-world primary care setting. BMJ Open 2017; 7:e013685.
Alpert BS, Quinn D, Gallick D: Oscillometric blood pressure: a review for clinicians. J Am Soc Hypertens 2014; 8:930-938.
NICE: WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension http://guidance.nice.org.uk/MTG13. 2013; Assessed 18 Aug. 2015.
